These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 434672)

  • 21. [Successful treatment of progressive dialysis encephalopathy. Case report].
    Weiland P; Köhler M; Glatzel E
    Z Urol Nephrol; 1985 Jul; 78(7):387-93. PubMed ID: 4050157
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Water content of aluminum, dialysis dementia, and osteomalacia.
    Wills MR; Savory J
    Environ Health Perspect; 1985 Nov; 63():141-7. PubMed ID: 3908086
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aluminium ion: metabolism and toxicity.
    Berlyne GM; Rubin JE
    J Hum Nutr; 1977 Dec; 31(6):439-42. PubMed ID: 591720
    [No Abstract]   [Full Text] [Related]  

  • 24. The metabolism of aluminum and aluminum-related encephalopathy.
    Mayor GH; Burnatowska-Hledin M
    Semin Nephrol; 1986 Dec; 6(4 Suppl 1):1-4. PubMed ID: 3299587
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low serum aluminum values in dialysis patients with increased bone aluminum levels.
    van Landeghem GF; D'Haese PC; Lamberts LV; Djukanovic L; Pejanovic S; Goodman WG; De Broe ME
    Clin Nephrol; 1998 Aug; 50(2):69-76. PubMed ID: 9725776
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative evaluation of bone aluminum content and bone histology in patients on chronic hemodialysis and hemofiltration.
    Sebert JL; Fournier A; Leflon P; Fohrer P; de Frémont JF; Morinière P; Galy C; Marie A; Demontis R; Boudailliez B
    Nephron; 1986; 42(1):34-40. PubMed ID: 3941748
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk factors in aluminum toxicity in children with chronic renal failure.
    Santos F; Massie MD; Chan JC
    Nephron; 1986; 42(3):189-95. PubMed ID: 3511396
    [No Abstract]   [Full Text] [Related]  

  • 28. [The natural history of dialysis encephalopathy (author's transl)].
    Pogglitsch H; Wawschinek O; Holzer H; Petek W; Ladurner G; Katschnig H; Korthals C
    Acta Med Austriaca; 1980; 7(3):71-6. PubMed ID: 7223340
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aluminum related dialysis osteomalacia and dementia after prolonged use of the Redy cartridge.
    Pierides AM; Frohnert PP
    Trans Am Soc Artif Intern Organs; 1981; 27():629-33. PubMed ID: 7331145
    [No Abstract]   [Full Text] [Related]  

  • 30. Bone aluminum deposition in maintenance dialysis patients treated with aluminium-free dialysate: role of aluminium hydroxide consumption.
    Heaf JG; Pødenphant J; Andersen JR
    Nephron; 1986; 42(3):210-6. PubMed ID: 3945361
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The effect of chronic renal insufficiency with and without dialysis therapy on the manganese content of various human organs].
    Stein G; Anke M; Fünfstück R; Schneider HJ
    Z Gesamte Inn Med; 1979 Nov; 34(21):648-51. PubMed ID: 550617
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Editorial: Dialysis dementia: aluminium again?
    Lancet; 1976 Feb; 1(7955):349. PubMed ID: 54751
    [No Abstract]   [Full Text] [Related]  

  • 33. Aluminum neurotoxicity and Alzheimer's disease.
    Still CN
    J S C Med Assoc; 1994 Nov; 90(11):560-4. PubMed ID: 7853860
    [No Abstract]   [Full Text] [Related]  

  • 34. Aluminum and phosphate: the double bind.
    Kaye M; Gagnon R
    Am J Kidney Dis; 1985 Nov; 6(5):365-7. PubMed ID: 3904430
    [No Abstract]   [Full Text] [Related]  

  • 35. Quantitation and localisation of aluminum in human cancellous bone in renal osteodystrophy.
    Boyce BF; Eider HY; Fell SG; Nicholson WA; Smith GD; Dempster DW; Gray CC; Boyle IT
    Scan Electron Microsc; 1981; (Pt 3):329-37. PubMed ID: 7330581
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The fatal interplay of aluminum and citrate in chronic renal failure: a lesson from three decades ago.
    Bakir AA
    Artif Organs; 2015 Feb; 39(2):87-9. PubMed ID: 25683287
    [No Abstract]   [Full Text] [Related]  

  • 37. Diagnosis and treatment of aluminium overload in end-stage renal failure patients.
    Nephrol Dial Transplant; 1993; 8 Suppl 1():1-4. PubMed ID: 8389013
    [No Abstract]   [Full Text] [Related]  

  • 38. Serum aluminum levels in dialysis dementia.
    McKinney TD; Basinger M; Dawson E; Jones MM
    Nephron; 1982; 32(1):53-6. PubMed ID: 7177277
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Brain gamma-aminobutyric acid deficiency in dialysis encephalopathy.
    Sweeney VP; Perry TL; Price JD; Reeve CE; Godolphin WJ; Kish SJ
    Neurology; 1985 Feb; 35(2):180-4. PubMed ID: 3969205
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aluminum and phosphate.
    Kaye M; Turner M; Ardila M; Wiegmann T; Hodsman A
    Kidney Int Suppl; 1988 Mar; 24():S172-4. PubMed ID: 3163042
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.